Who has invested in Thymmune Therapeutics?

Pillar VC, NYBC Ventures are named among the investors backing Thymmune Therapeutics.

Thymmune Therapeutics Funding: $7M Raised, Seed (2023)

Thymmune Therapeutics funding overview

Thymmune Therapeutics is based in Cambridge. Thymmune Therapeutics has raised $7M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in March 2023. The round record for Thymmune Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Pillar VC, NYBC Ventures. 2 distinct backers are named across the disclosed rounds.

Thymmune Therapeutics at a glance

Total raised: $7M
Latest round: Seed
Latest round date: March 2023
Headquarters: Cambridge
Notable investors: Pillar VC, NYBC Ventures

Frequently asked about Thymmune Therapeutics funding

How much has Thymmune Therapeutics raised?: Thymmune Therapeutics has raised $7M in total disclosed funding across the rounds on record.
Who has invested in Thymmune Therapeutics?: Pillar VC, NYBC Ventures are named among the investors backing Thymmune Therapeutics.
What was the latest Thymmune Therapeutics funding round?: The most recent disclosed round is a Seed, announced in March 2023.
Where is Thymmune Therapeutics based?: Thymmune Therapeutics is based in Cambridge.
When did Thymmune Therapeutics last raise?: The last disclosed Thymmune Therapeutics round closed in March 2023 at Seed.

Totals shown for Thymmune Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Thymmune Therapeutics Funding: $7M Raised, Seed (2023)

Thymmune Therapeutics funding overview

Thymmune Therapeutics at a glance

Frequently asked about Thymmune Therapeutics funding

Companies related to Thymmune Therapeutics (30)

Browse related funding lists (6)